Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bellet

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1Marina M Bellet, Yasukazu Nakahata, Mohamed Boudjelal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2012
Management of the axilla in early breast cancer patients in the genomic eraM Oliveira, J Cortés, M Bellet, et al.
Journal of Fungi (Basel, Switzerland)|July 26, 2024
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary AspergillosisMarilena Pariano, Anna Gidari, Claudia Stincardini, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2013
Circadian clock regulates the host response to SalmonellaMarina M Bellet, Elisa Deriu, Janet Z Liu, et al.
Nature Medicine|June 27, 2018
Reply to 'F508del-CFTR is not corrected by thymosin α1'Luigina Romani, Claudia Stincardini, Stefano Giovagnoli, et al.
Life Science Alliance|November 14, 2019
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous diseaseGiorgia Renga, Vasilis Oikonomou, Silvia Moretti, et al.
Breast Cancer Research and Treatment|May 19, 2015
Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE studyMiguel J Gil-Gil, M Bellet, S Morales, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 11, 2011
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsC Serrano, J Cortés, L De Mattos-Arruda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsC Serrano, J Cortés, L De Mattos-Arruda, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2019
SEOM clinical guidelines in advanced and recurrent breast cancer (2018)J I Chacón López-Muñiz, L de la Cruz Merino, J Gavilá Gregori, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1Marina M Bellet, Yasukazu Nakahata, Mohamed Boudjelal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2012
Management of the axilla in early breast cancer patients in the genomic eraM Oliveira, J Cortés, M Bellet, et al.
Journal of Fungi (Basel, Switzerland)|July 26, 2024
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary AspergillosisMarilena Pariano, Anna Gidari, Claudia Stincardini, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2013
Circadian clock regulates the host response to SalmonellaMarina M Bellet, Elisa Deriu, Janet Z Liu, et al.
Nature Medicine|June 27, 2018
Reply to 'F508del-CFTR is not corrected by thymosin α1'Luigina Romani, Claudia Stincardini, Stefano Giovagnoli, et al.
Life Science Alliance|November 14, 2019
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous diseaseGiorgia Renga, Vasilis Oikonomou, Silvia Moretti, et al.
Breast Cancer Research and Treatment|May 19, 2015
Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE studyMiguel J Gil-Gil, M Bellet, S Morales, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 11, 2011
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsC Serrano, J Cortés, L De Mattos-Arruda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2019
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsC Serrano, J Cortés, L De Mattos-Arruda, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2019
SEOM clinical guidelines in advanced and recurrent breast cancer (2018)J I Chacón López-Muñiz, L de la Cruz Merino, J Gavilá Gregori, et al.
Pageof 16